Cell
Volume 185, Issue 5, 3 March 2022, Pages 881-895.e20
Journal home page for Cell

Article
Multiple early factors anticipate post-acute COVID-19 sequelae

https://doi.org/10.1016/j.cell.2022.01.014Get rights and content
Under a Creative Commons license
open access

Highlights

  • Longitudinal multi-omics associate PASC with auto-antibodies, viremia, and comorbidities

  • Reactivation of latent viruses during initial infection may contribute to PASC

  • Subclinical auto-antibodies negatively correlate with anti-SARS-CoV-2 antibodies

  • Gastrointestinal PASC uniquely present with post-acute expansion of cytotoxic T cells

Summary

Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2–3 months later), integrated with clinical data and patient-reported symptoms. We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies. In patients with gastrointestinal PASC, SARS-CoV-2-specific and CMV-specific CD8+ T cells exhibited unique dynamics during recovery from COVID-19. Analysis of symptom-associated immunological signatures revealed coordinated immunity polarization into four endotypes, exhibiting divergent acute severity and PASC. We find that immunological associations between PASC factors diminish over time, leading to distinct convalescent immune states. Detectability of most PASC factors at COVID-19 diagnosis emphasizes the importance of early disease measurements for understanding emergent chronic conditions and suggests PASC treatment strategies.

Keywords

multi-omics
COVID-19
PASC
proteomics
metabolomics
immune system
single-cell TCR-seq
single-cell RNA-seq
single-cell CITE-seq
single-cell secretome
long COVID
symptoms
single cell
transcriptome
computational biology
immunology
viremia
RNAemia
auto-antibodies
antibodies

Data and code availability

  • All PBMC sc-RNA-seq data used in this study can be accessed by Array Express under the accession number: E-MTAB-10129. Additional Supplemental Items are available at Mendeley Data: https://doi.org/10.17632/96v329bg7g.1.

  • This paper does not report original code.

  • Any additional information required to reanalyze the data reported in this work paper is available from the lead contact upon request.

Cited by (0)

28

These authors contributed equally

29

Lead contact